Total investments received (USD): 11.8m
Round value (USD): 11.8m
Round investors:
Takeda Pharmaceutical Company Limited
Demcon
OostNL
Novalis Biotech
i&i Biotech Fund
Company: Enzyre
Industry:
Health services
Software Services





Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom